169 related articles for article (PubMed ID: 31147200)
61. Erdosteine protects HEI-OC1 auditory cells from cisplatin toxicity through suppression of inflammatory cytokines and induction of Nrf2 target proteins.
Kim SJ; Park C; Lee JN; Lim H; Hong GY; Moon SK; Lim DJ; Choe SK; Park R
Toxicol Appl Pharmacol; 2015 Oct; 288(2):192-202. PubMed ID: 26193055
[TBL] [Abstract][Full Text] [Related]
62. Erdosteine enhances airway response to salbutamol in patients with mild-to-moderate COPD.
Dal Negro R; Visconti M; Trevisan F; Bertacco S; Micheletto C; Tognella S
Ther Adv Respir Dis; 2008 Oct; 2(5):271-7. PubMed ID: 19124377
[TBL] [Abstract][Full Text] [Related]
63. Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease.
Biswas S; Hwang JW; Kirkham PA; Rahman I
Curr Med Chem; 2013; 20(12):1496-530. PubMed ID: 22963552
[TBL] [Abstract][Full Text] [Related]
64. Antioxidant therapeutic targets in COPD.
Rahman I; Kilty I
Curr Drug Targets; 2006 Jun; 7(6):707-20. PubMed ID: 16787173
[TBL] [Abstract][Full Text] [Related]
65. Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: a 15-day, prospective, parallel, open-label, pilot study.
Crisafulli E; Coletti O; Costi S; Zanasi E; Lorenzi C; Lucic S; Fabbri LM; Bertini M; Clini EM
Clin Ther; 2007 Sep; 29(9):2001-9. PubMed ID: 18035199
[TBL] [Abstract][Full Text] [Related]
66. Thiol antioxidant reversal of pyrrolidine dithiocarbamate-induced reciprocal regulation of AP-1 and NF-kappaB.
Kim CH; Kim JH; Lee J; Hsu CY; Ahn YS
Biol Chem; 2003 Jan; 384(1):143-50. PubMed ID: 12674508
[TBL] [Abstract][Full Text] [Related]
67. Antioxidant strategies in respiratory medicine.
Christofidou-Solomidou M; Muzykantov VR
Treat Respir Med; 2006; 5(1):47-78. PubMed ID: 16409015
[TBL] [Abstract][Full Text] [Related]
68. Effect of green tea extract (catechins) in reducing oxidative stress seen in patients of pulmonary tuberculosis on DOTS Cat I regimen.
Agarwal A; Prasad R; Jain A
Phytomedicine; 2010 Jan; 17(1):23-7. PubMed ID: 19910173
[TBL] [Abstract][Full Text] [Related]
69. Medicinal Thiols: Current Status and New Perspectives.
Pfaff AR; Beltz J; King E; Ercal N
Mini Rev Med Chem; 2020; 20(6):513-529. PubMed ID: 31746294
[TBL] [Abstract][Full Text] [Related]
70. N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease.
Sadowska AM
Ther Adv Respir Dis; 2012 Jun; 6(3):127-35. PubMed ID: 22361928
[TBL] [Abstract][Full Text] [Related]
71. Thiol antioxidants inhibit the adjuvant effects of aerosolized diesel exhaust particles in a murine model for ovalbumin sensitization.
Whitekus MJ; Li N; Zhang M; Wang M; Horwitz MA; Nelson SK; Horwitz LD; Brechun N; Diaz-Sanchez D; Nel AE
J Immunol; 2002 Mar; 168(5):2560-7. PubMed ID: 11859152
[TBL] [Abstract][Full Text] [Related]
72. Antioxidant effect of erdosteine and lipoic acid in ovarian ischemia-reperfusion injury.
Dokuyucu R; Karateke A; Gokce H; Kurt RK; Ozcan O; Ozturk S; Tas ZA; Karateke F; Duru M
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():23-7. PubMed ID: 25461347
[TBL] [Abstract][Full Text] [Related]
73. Modulation of airway hyperresponsiveness by thiols in a murine in vivo model of allergic asthma.
Kloek J; Van Ark I; De Clerck F; Bloksma N; Nijkamp FP; Folkerts G
Inflamm Res; 2003 Mar; 52(3):126-31. PubMed ID: 12755377
[TBL] [Abstract][Full Text] [Related]
74. Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease.
Calzetta L; Matera MG; Rogliani P; Cazzola M
Expert Rev Respir Med; 2018 Aug; 12(8):693-708. PubMed ID: 29972340
[TBL] [Abstract][Full Text] [Related]
75. The antiatherogenic effect of bixin in hypercholesterolemic rabbits is associated to the improvement of lipid profile and to its antioxidant and anti-inflammatory effects.
Somacal S; Figueiredo CG; Quatrin A; Ruviaro AR; Conte L; Augusti PR; Roehrs M; Denardin IT; Kasten J; da Veiga ML; Duarte MM; Emanuelli T
Mol Cell Biochem; 2015 May; 403(1-2):243-53. PubMed ID: 25702177
[TBL] [Abstract][Full Text] [Related]
76. Effects of aminoguanidine and antioxidant erdosteine on bleomycin-induced lung fibrosis in rats.
Yildirim Z; Turkoz Y; Kotuk M; Armutcu F; Gurel A; Iraz M; Ozen S; Aydogdu I; Akyol O
Nitric Oxide; 2004 Sep; 11(2):156-65. PubMed ID: 15491848
[TBL] [Abstract][Full Text] [Related]
77. The evidence for the use of oral mucolytic agents in chronic obstructive pulmonary disease (COPD).
Davies L; Calverley PM
Br Med Bull; 2010; 93():217-27. PubMed ID: 20031934
[TBL] [Abstract][Full Text] [Related]
78. Radiation-induced micronucleus formation and DNA damage in human lymphocytes and their prevention by antioxidant thiols.
Tiwari P; Kumar A; Balakrishnan S; Kushwaha HS; Mishra KP
Mutat Res; 2009 May; 676(1-2):62-8. PubMed ID: 19486866
[TBL] [Abstract][Full Text] [Related]
79. Thiol and redox reactive agents exert different effects on glutathione metabolism in HeLa cell cultures.
Hultberg B; Andersson A; Isaksson A
Clin Chim Acta; 1999 May; 283(1-2):21-32. PubMed ID: 10404728
[TBL] [Abstract][Full Text] [Related]
80. [The application of N-acetylcysteine in optimization of specific pharmacological therapies].
Hołyńska-Iwan I; Wróblewski M; Olszewska-Słonina D; Tyrakowski T
Pol Merkur Lekarski; 2017 Sep; 43(255):140-144. PubMed ID: 28987048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
